The MObile AssessMENT of Behavioral and Psychological Symptoms of Dementia in Amnestic MCI and AD (MOMENT) Study
NCT04482036 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2023-09-01
Summary
The purpose of this research study is to learn whether it is possible and useful for caregivers to report behavioral or psychological symptoms of people with mild memory problems or Alzheimer's disease through a smartphone mobile application. The investigators believe that monitoring these symptoms and having a tool, like a mobile application, can provide quicker accessibility to the patient's clinical care team, which could improve care for patients and caregivers.
These types of symptoms found in patients with mild memory problems or Alzheimer's disease are any type of psychiatric symptoms or abnormal behaviors one might develop as the result of these brain illnesses. Examples of psychological and behavioral symptoms are depression, anxiety, insomnia, irritability, agitation, and hallucinations. These symptoms differ from regular psychiatric symptoms, because they are caused by mild memory problems or Alzheimer's disease (AD). These symptoms can cause a lot of distress for patients and caregivers, and can lead to greater use of healthcare services.
Conditions
- Alzheimer Disease
- Mild Memory Disturbance
- Mild Cognitive Impairment
Interventions
- OTHER
-
Mobile Phone Application Assessments
The BrainCare Notes app was designed to be installed on the caregiver's phone. It has the capacity to send Neuropsychiatric Inventory Questionnaire (NPI-Q) assessments to the caregiver. If the answers to the behavioral and psychological symptoms rise above the threshold, the clinicians will be notified, and a care plan will be enacted, in order to keep the patient and caregiver safe. The application also has the ability to send and receive private messages between caregiver and the patient's clinical care team.
- OTHER
-
Standard Assessments
The caregiver and patient will receive the same questionnaires and surveys that the intervention group will receive. However, they will not receive the mobile phone application questionnaires.
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH -
Indiana University
lead OTHER
Principal Investigators
-
Daniel R Bateman, MD · Indiana University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-23
- Primary Completion
- 2021-10-04
- Completion
- 2021-10-04
Countries
- United States
Study Locations
More Related Trials
-
Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
NCT02322021 ·Status: TERMINATED ·Phase: PHASE2
-
Corticolimbic Degeneration and Treatment of Dementia
NCT00768261 ·Status: COMPLETED ·Phase: PHASE4
-
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome
NCT02854917 ·Status: COMPLETED
-
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
NCT00933608 ·Status: COMPLETED ·Phase: PHASE4
-
APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
NCT04994847 ·Status: ENROLLING_BY_INVITATION
-
Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
NCT00722046 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine Treatment in Alzheimer's Disease Patients
NCT03168997 ·Status: UNKNOWN ·Phase: PHASE4
-
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
NCT00120874 ·Status: COMPLETED ·Phase: PHASE4
-
Memory Aid for Informed Consent in Alzheimer's Research
NCT00105612 ·Status: COMPLETED ·Phase: NA
-
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
NCT00097916 ·Status: COMPLETED ·Phase: PHASE3
-
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
NCT03486938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease
NCT00800709 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
NCT02079909 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
NCT00257673 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancing Consent for Alzheimer's Research
NCT00453544 ·Status: COMPLETED ·Phase: NA
-
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
NCT04623242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
NCT00663936 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)
NCT00777608 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC
NCT00544453 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
NCT00334906 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
NCT03044249 ·Status: TERMINATED ·Phase: PHASE2
-
Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
NCT01082965 ·Status: TERMINATED ·Phase: NA